Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial)
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference36 articles.
1. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction;Brener;Circulation,1998
2. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction;Neumann;J Am Coll Cardiol,2000
3. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction;Montalescot;N Engl J Med,2001
4. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction;Antoniucci;J Am Coll Cardiol,2003
5. Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis;Montalescot;JAMA,2004
Cited by 96 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiplatelet Therapy in Coronary Artery Disease: Now and Then;Seminars in Thrombosis and Hemostasis;2022-12-01
2. Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI;Reviews in Cardiovascular Medicine;2022-09-05
3. Antiplatelet Agents in Acute ST Elevation Myocardial Infarction;The American Journal of Medicine;2022-06
4. Acute Coronary Syndromes (ACS)—Unravelling Biology to Identify New Therapies—The Microcirculation as a Frontier for New Therapies in ACS;Cells;2021-08-25
5. Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction—Prevalence, Importance and Approaches to Management;Cardiovascular Drugs and Therapy;2021-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3